BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21151127)

  • 1. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
    Melum E; Franke A; Schramm C; Weismüller TJ; Gotthardt DN; Offner FA; Juran BD; Laerdahl JK; Labi V; Björnsson E; Weersma RK; Henckaerts L; Teufel A; Rust C; Ellinghaus E; Balschun T; Boberg KM; Ellinghaus D; Bergquist A; Sauer P; Ryu E; Hov JR; Wedemeyer J; Lindkvist B; Wittig M; Porte RJ; Holm K; Gieger C; Wichmann HE; Stokkers P; Ponsioen CY; Runz H; Stiehl A; Wijmenga C; Sterneck M; Vermeire S; Beuers U; Villunger A; Schrumpf E; Lazaridis KN; Manns MP; Schreiber S; Karlsen TH
    Nat Genet; 2011 Jan; 43(1):17-9. PubMed ID: 21151127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.
    Srivastava B; Mells GF; Cordell HJ; Muriithi A; Brown M; Ellinghaus E; Franke A; ; Karlsen TH; Sandford RN; Alexander GJ; Chapman RW; Rushbrook SM; Melum E
    Scand J Gastroenterol; 2012 Jul; 47(7):820-6. PubMed ID: 22554193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association analysis in primary sclerosing cholangitis.
    Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
    Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association studies in primary sclerosing cholangitis: still more questions than answers?
    Chapman R
    Hepatology; 2011 Jun; 53(6):2133-5. PubMed ID: 21618262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
    Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
    Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma.
    Krawczyk M; Höblinger A; Mihalache F; Grünhage F; Acalovschi M; Lammert F; Zimmer V
    Dig Liver Dis; 2013 Jul; 45(7):612-5. PubMed ID: 23422030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
    Folseraas T; Melum E; Rausch P; Juran BD; Ellinghaus E; Shiryaev A; Laerdahl JK; Ellinghaus D; Schramm C; Weismüller TJ; Gotthardt DN; Hov JR; Clausen OP; Weersma RK; Janse M; Boberg KM; Björnsson E; Marschall HU; Cleynen I; Rosenstiel P; Holm K; Teufel A; Rust C; Gieger C; Wichmann HE; Bergquist A; Ryu E; Ponsioen CY; Runz H; Sterneck M; Vermeire S; Beuers U; Wijmenga C; Schrumpf E; Manns MP; Lazaridis KN; Schreiber S; Baines JF; Franke A; Karlsen TH
    J Hepatol; 2012 Aug; 57(2):366-75. PubMed ID: 22521342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.
    Janse M; Lamberts LE; Franke L; Raychaudhuri S; Ellinghaus E; Muri Boberg K; Melum E; Folseraas T; Schrumpf E; Bergquist A; Björnsson E; Fu J; Jan Westra H; Groen HJ; Fehrmann RS; Smolonska J; van den Berg LH; Ophoff RA; Porte RJ; Weismüller TJ; Wedemeyer J; Schramm C; Sterneck M; Günther R; Braun F; Vermeire S; Henckaerts L; Wijmenga C; Ponsioen CY; Schreiber S; Karlsen TH; Franke A; Weersma RK
    Hepatology; 2011 Jun; 53(6):1977-85. PubMed ID: 21425313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
    Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
    BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.
    Betz RC; Petukhova L; Ripke S; Huang H; Menelaou A; Redler S; Becker T; Heilmann S; Yamany T; Duvic M; Hordinsky M; Norris D; Price VH; Mackay-Wiggan J; de Jong A; DeStefano GM; Moebus S; Böhm M; Blume-Peytavi U; Wolff H; Lutz G; Kruse R; Bian L; Amos CI; Lee A; Gregersen PK; Blaumeiser B; Altshuler D; Clynes R; de Bakker PIW; Nöthen MM; Daly MJ; Christiano AM
    Nat Commun; 2015 Jan; 6():5966. PubMed ID: 25608926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
    Liu JZ; Hov JR; Folseraas T; Ellinghaus E; Rushbrook SM; Doncheva NT; Andreassen OA; Weersma RK; Weismüller TJ; Eksteen B; Invernizzi P; Hirschfield GM; Gotthardt DN; Pares A; Ellinghaus D; Shah T; Juran BD; Milkiewicz P; Rust C; Schramm C; Müller T; Srivastava B; Dalekos G; Nöthen MM; Herms S; Winkelmann J; Mitrovic M; Braun F; Ponsioen CY; Croucher PJ; Sterneck M; Teufel A; Mason AL; Saarela J; Leppa V; Dorfman R; Alvaro D; Floreani A; Onengut-Gumuscu S; Rich SS; Thompson WK; Schork AJ; Næss S; Thomsen I; Mayr G; König IR; Hveem K; Cleynen I; Gutierrez-Achury J; Ricaño-Ponce I; van Heel D; Björnsson E; Sandford RN; Durie PR; Melum E; Vatn MH; Silverberg MS; Duerr RH; Padyukov L; Brand S; Sans M; Annese V; Achkar JP; Boberg KM; Marschall HU; Chazouillères O; Bowlus CL; Wijmenga C; Schrumpf E; Vermeire S; Albrecht M; ; Rioux JD; Alexander G; Bergquist A; Cho J; Schreiber S; Manns MP; Färkkilä M; Dale AM; Chapman RW; Lazaridis KN; ; Franke A; Anderson CA; Karlsen TH;
    Nat Genet; 2013 Jun; 45(6):670-5. PubMed ID: 23603763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights into autoimmune liver diseases provided by genome-wide association studies.
    Mells GF; Kaser A; Karlsen TH
    J Autoimmun; 2013 Oct; 46():41-54. PubMed ID: 23931959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease.
    Häuser F; Deyle C; Berard D; Neukirch C; Glowacki C; Bickmann JK; Wenzel JJ; Lackner KJ; Rossmann H
    Genes Immun; 2012 Jun; 13(4):321-7. PubMed ID: 22237417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.
    Ji SG; Juran BD; Mucha S; Folseraas T; Jostins L; Melum E; Kumasaka N; Atkinson EJ; Schlicht EM; Liu JZ; Shah T; Gutierrez-Achury J; Boberg KM; Bergquist A; Vermeire S; Eksteen B; Durie PR; Farkkila M; Müller T; Schramm C; Sterneck M; Weismüller TJ; Gotthardt DN; Ellinghaus D; Braun F; Teufel A; Laudes M; Lieb W; Jacobs G; Beuers U; Weersma RK; Wijmenga C; Marschall HU; Milkiewicz P; Pares A; Kontula K; Chazouillères O; Invernizzi P; Goode E; Spiess K; Moore C; Sambrook J; Ouwehand WH; Roberts DJ; Danesh J; Floreani A; Gulamhusein AF; Eaton JE; Schreiber S; Coltescu C; Bowlus CL; Luketic VA; Odin JA; Chopra KB; Kowdley KV; Chalasani N; Manns MP; Srivastava B; Mells G; Sandford RN; Alexander G; Gaffney DJ; Chapman RW; Hirschfield GM; de Andrade M; ; ; ; Rushbrook SM; Franke A; Karlsen TH; Lazaridis KN; Anderson CA
    Nat Genet; 2017 Feb; 49(2):269-273. PubMed ID: 27992413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic epidemiology of primary sclerosing cholangitis.
    Karlsen TH; Schrumpf E; Boberg KM
    World J Gastroenterol; 2007 Nov; 13(41):5421-31. PubMed ID: 17907284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.
    Naess S; Björnsson E; Anmarkrud JA; Al Mamari S; Juran BD; Lazaridis KN; Chapman R; Bergquist A; Melum E; Marsh SG; Schrumpf E; Lie BA; Boberg KM; Karlsen TH; Hov JR
    Liver Int; 2014 Nov; 34(10):1488-95. PubMed ID: 24517468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.
    Eksteen B
    Br Med Bull; 2014 Jun; 110(1):89-98. PubMed ID: 24795363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.
    Næss S; Lie BA; Melum E; Olsson M; Hov JR; Croucher PJ; Hampe J; Thorsby E; Bergquist A; Traherne JA; Schrumpf E; Boberg KM; Schreiber S; Franke A; Karlsen TH
    PLoS One; 2014; 9(12):e114486. PubMed ID: 25521205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut-Liver Axis in Primary Sclerosing Cholangitis.
    Eksteen B
    Clin Liver Dis; 2016 Feb; 20(1):1-14. PubMed ID: 26593287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
    Yang X; Cullen SN; Li JH; Chapman RW; Jewell DP
    J Hepatol; 2004 Mar; 40(3):375-9. PubMed ID: 15123348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.